The All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
The gang behind a £19million cocaine conspiracy are being sentenced in one of Dyfed-Powys Police's biggest ever operations.
Some interesting weather to start the weekend, with a yellow warning to "Be Aware" of heavy rain! But it will get better!
When a wave took a woman's false leg into the sea at Freshwater East, Gertie the dog knew she only had one chance - and leapt into action.